Parker Names New Exoskeleton Device Indego™
- Name highlights enhanced patient independence promoted by lightweight,
- Device provides individuals with spinal cord injury and stroke the
opportunity to walk again
CLEVELAND, Jan. 21, 2013
CLEVELAND, Jan. 21, 2013 /PRNewswire/ --Parker Hannifin Corporation (NYSE:
PH), the global leader in motion and control technologies, today announced
that it will market its new exoskeleton device under the name Indego™. Parker
recently announced an exclusive licensing agreement with Vanderbilt University
for its exoskeleton technology, which allows individuals with severe spinal
cord injury to walk and enhances rehabilitation for people who have suffered a
stroke. The agreement gives Parker exclusive rights to develop, manufacture
and sell the device, subsequent to the appropriate regulatory clearances.
Parker intends to invest in further development of the technology and
establish a business unit targeting commercial launch of the exoskeleton
device in 2014.
(Photo: http://photos.prnewswire.com/prnh/20130121/CL45068-b )
(Logo: http://photos.prnewswire.com/prnh/19990816/PHLOGO )
"We believe the name Indego captures the essence of the device, highlighting
the primary benefit of enhanced independence," said Craig Maxwell, Vice
President of Technology and Innovation for Parker. "The design objective of
the team has always been to provide a solution that functions as a natural
extension of the user. Indego's compact, lightweight and intuitive design
creates a seamless interface between man and machine. These features will
become increasingly important as we extend availability of the device beyond
the clinical setting and into the personal mobility space."
Indego weighs just 27lbs which is nearly 50% lighter than other exoskeletons.
The device also has a slim profile and no footplates or bulky backpack
components, enabling a user to wear the device even while sitting in their own
wheelchair. Its modular design allows users the ability to quickly assemble
and disassemble the device for ease of use and transportation.
Two additional advantages from a rehabilitative perspective: the amount of
robotic assistance adjusts automatically for users who have some muscle
control in their legs and it is the only wearable exoskeleton that
incorporates functional electrical stimulation, a proven rehabilitation
Indego is currently being tested and refined through clinical research at the
Shepherd Center in Atlanta, Georgia, one of the foremost rehabilitation
hospitals in the United States. Patient and clinician feedback on the device
has been overwhelmingly positive and the Center has concluded that the device
has the most promise as a rehabilitation and home device.
To learn more about Indego please visit: http://Indego.parker.com
With annual sales exceeding $13 billion in fiscal year 2012, Parker Hannifin
is the world's leading diversified manufacturer of motion and control
technologies and systems, providing precision-engineered solutions for a wide
variety of mobile, industrial and aerospace markets. The company employs
approximately 60,000 people in 48 countries around the world. Parker has
increased its annual dividends paid to shareholders for 56 consecutive fiscal
years, among the top five longest-running dividend-increase records in the S&P
500 index. For more information, visit the company's web site at
www.parker.com or its investor information web site at www.phstock.com.
SOURCE Parker Hannifin Corporation
Contact: Media - Aidan Gormley, Director, Corporate Communications,
+1-216-896-3258, firstname.lastname@example.org; or Financial Analysts - Pamela
Huggins, Vice President - Treasurer, +1-216-896-2240, email@example.com
Press spacebar to pause and continue. Press esc to stop.